摘要
体外受精-胚胎移植(IVF-ET)技术是不孕症的主要治疗手段之一,但其操作过程复杂,费用昂贵,且在大多数发展中国家没有纳入社会医疗保险。因此,如何以最低的成本获取最大的成功率是临床医生和患者共同关心的问题。目前关于IVF-ET技术中的经济学研究主要集中在不同促排卵药物、不同促排卵方案、不同移植方式及移植个数等方面,但IVF-ET技术过程复杂,相关经济学研究方法多样,结局指标目前没有统一的标准,何种为更经济有效的方案也没有统一的定论。因此,分析IVF-ET技术中的经济学研究,探讨总结更合适的评价方法及更经济有效的方案,不仅可以合理分配医疗卫生资源,指导临床选择,还可以为今后IVF-ET治疗费用纳入医保提供重要的参考依据。
In vitro fertilization and embryo transplantation(IVF-ET) technology is one of the main treatments for infertility. But IVF-ET is expensive and has not be covered by health insurance in most developing countries. Therefore, how to obtain the maximum success rate with the minimum cost is a common concern of clinicians and patients. At present, the economic studies on IVF-ET mainly focus on different ovulation stimulating drugs, different ovulation stimulating protocols, different transplantation methods and the number of transplants. But the process of IVF-ET is complex, the relevant methods of economic study are diverse, and there are no unified standard for outcome indicators, so there is no unified conclusion for more economical and effective protocol by now. Therefore, to analyze the economic studies of IVF-ET, and to explore appropriate evaluation methods and cost-effective protocols will be helpful for reasonable allocation of medical resources and guidance of clinical selection. It would provide policy reference to include the costs of IVF-ET treatment in health insurance in the future.
作者
井苗苗
张润驹
JING Miaomniao;ZHANG Runju(Department of Reprodulctive Endocrinology,Women's,Hospital,Zhejiang University School of Medicine,Hangzhou 310006,China)
出处
《浙江大学学报（医学版）》
CAS
CSCD
北大核心
2019年第5期580-585,共6页
Journal of Zhejiang University(Medical Sciences)
基金
国家自然科学基金(81300464)
浙江省医药卫生科技计划(2015128465)
关键词
胚胎移植/经济学
体外受精/经济学
经济学
药学
成本及成本分析
费用效益分析
Embryo transfer/economics
Fertilization in vitro/economics
Economics,pharmaceutical
Costs and cost analysis
Cost-benefit analysis
